SAMHSA Data Waiver (X-waiver) Guidelines/DEA Guidelines for treating patients with Opioid Use Disorder - Sarah Hamauei, MD

2021 Virtual Community Opioid Symposium: July 28, 2021

SAMHSA Data Waiver (X-waiver) Guidelines/DEA Guidelines for treating patients with Opioid Use Disorder – Sarah Hamauei, MD

Learning Objectives:

1. Define/describe SAMHSA, DATA/X-waiver, and give overview of OUD treatment in this context.

2. Identify resources for those wishing to obtain the waiver, both for initial certification and ongoing support.

3. Review ongoing changes and updates to DATA-waiver requirements

4. Demonstrate use in clinical vignettes to show real-world application of waiver, including cases where it is not required.